InfuSystem Holdings, Inc·4

May 14, 6:31 PM ET

HUSS BEVERLY A 4

4 · InfuSystem Holdings, Inc · Filed May 14, 2026

Research Summary

AI-generated summary of this filing

Updated

InfuSystem (INFU) Director Beverly A. Huss Receives Option Award

What Happened

  • Beverly A. Huss, a director of InfuSystem Holdings, Inc. (INFU), was granted a derivative award on 2026-05-12 representing the right to purchase 24,890 shares. The Form 4 reports the acquisition at $0.00 (derivative), indicating a grant of an option-like award rather than an immediate purchase or sale. The award vests on May 12, 2027 (footnote F1).

Key Details

  • Transaction date: 2026-05-12; Form 4 filed: 2026-05-14.
  • Instrument: Option/derivative right to purchase 24,890 shares; reported acquisition price $0.00.
  • Vesting: The award vests on May 12, 2027 (per footnote F1).
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Filing timeliness: Filed two days after the transaction (within the typical Form 4 reporting window based on the dates shown).

Context

  • This was a grant of an option-style award for director compensation, not an exercise or sale, so it does not change outstanding common shares until (and unless) the option is exercised. Such awards are commonly used for retention and compensation and should be interpreted as planned compensation rather than an immediate bullish or bearish trading signal.

Insider Transaction Report

Form 4
Period: 2026-05-12
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-05-12+24,89024,890 total
    Exercise: $8.37From: 2027-05-12Exp: 2036-05-12Common Stock (24,890 underlying)
Holdings
  • Common Stock

    4,300
Footnotes (1)
  • [F1]The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027.
Signature
/s/ Kevin Whitman, Attorney-in-Fact for Beverly A. Huss|2026-05-14

Documents

1 file
  • 4
    wk-form4_1778797913.xmlPrimary

    FORM 4